You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Insulin therapy

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Boston (Pembrolizumab, Nab-Paclitaxel, Biopsy)

Active, not recruiting
  • Breast Cancer
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Aug 22, 2022

Sickle Cell Disease Trial in Boston (Autologous CD34+ HSC cells transduced with the lentiviral vector containing a shRNA

Recruiting
  • Sickle Cell Disease
  • Autologous CD34+ HSC cells transduced with the lentiviral vector containing a shRNA targeting BCL11a
  • Los Angeles, California
  • +8 more
Jan 10, 2023

Head Neck Cancer, Head and Neck Squamous Cell Carcinoma, Oropharynx Cancer Trial (ENDURE)

Not yet recruiting
  • Head and Neck Cancer
  • +4 more
  • ENDURE
  • (no location specified)
Apr 2, 2023

Helicobacter Pylori Infection, Chronic Gastritis Trial in Xi'an (Berberine, Vonoprazan, Amoxicillin)

Recruiting
  • Helicobacter Pylori Infection
  • Chronic Gastritis
  • Xi'an, Shaanxi, China
    Xijing Hosipital of Digestive Disease
Nov 23, 2021

Neuroblastoma Trial (Naxitamab)

Not yet recruiting
  • Neuroblastoma
  • (no location specified)
Sep 18, 2023

HLH Trial in Beijing (Teniposide)

Recruiting
  • HLH
  • Beijing, China
    Zhao Wang
Sep 15, 2023

OCD Trial in Braga (ICBT)

Recruiting
  • Obsessive-Compulsive Disorder
  • ICBT
  • Braga, Gualtar, Portugal
    Life and Health Sciences Research Institute, School of Medicine,
Jun 6, 2023

NSCLC Stage IV Trial in Gauting (combination regimen tremelimumab /durvalumab, platinum-based chemo (SoC))

Withdrawn
  • NSCLC Stage IV
  • combination regimen tremelimumab /durvalumab
  • platinum-based chemotherapy (SoC)
  • Gauting, Germany
    Asklepios Fachkliniken München-Gauting
Sep 26, 2022

Friedreich Ataxia, Cardiomyopathy, Secondary Trial in United States (Low dose LX2006, High Dose LX2006)

Recruiting
  • Friedreich Ataxia
  • Cardiomyopathy, Secondary
  • Low dose LX2006
  • High Dose LX2006
  • Los Angeles, California
  • +3 more
Dec 2, 2022

Cognitive Aftereffects of Neurotoxicity in Children and Young

Not yet recruiting
  • Lymphoma
  • Leukemia
    • Los Angeles, California
    • +2 more
    Feb 2, 2023

    Critical Illness, Acute Kidney Injury Trial in Münster (Effluent dose of CRRT)

    Not yet recruiting
    • Critical Illness
    • Acute Kidney Injury
    • Effluent dose of CRRT
    • Münster, Germany
      University Hospital Münster
    Aug 31, 2023

    Low Back Pain Trial in Madrid (Group 1 (Physical Therapy+Magnetic Field Therapy), Group 2 (Physical Therapy))

    Not yet recruiting
    • Low Back Pain
    • Group 1 (Physical Therapy+Magnetic Field Therapy)
    • Group 2 (Physical Therapy)
    • Madrid, Spain
      Complutense University of Madrid
    Jan 17, 2022

    Visualizing Vascular Mechanisms of Lipedema

    Recruiting
    • Lipedema
      • Nashville, Tennessee
        Vanderbilt University Medical Center
      Jul 18, 2022

      Congenital Heart Disease, Mother Child Interaction Trial in Zurich (Creative Music Therapy)

      Recruiting
      • Congenital Heart Disease
      • Mother Child Interaction
      • Creative Music Therapy
      • Zurich, Switzerland
        University Children's Hospital Zurich
      Jan 17, 2023

      Appetite and General Nutritional Disorders Trial in London (Whey protein isolate, Potato protein isolate, Rice protein isolate)

      Completed
      • Appetite and General Nutritional Disorders
      • Whey protein isolate
      • +2 more
      • London, Greater London, United Kingdom
        University of Westminster
      May 2, 2021

      Artemis (DCLRE1C ) Deficient Severe Combined Immunodeficiency Trial in Paris (ARTEGENE drug product)

      Not yet recruiting
      • Artemis (DCLRE1C ) Deficient Severe Combined Immunodeficiency
      • ARTEGENE drug product
      • Paris, France
        Department of Pediatric Immunology, Hematology and Rheumatology
      Sep 26, 2022

      Breast Cancer Trial in United States (Letrozole, Ribociclib, Placebo)

      Active, not recruiting
      • Breast Cancer
      • Little Rock, Arkansas
      • +12 more
      Sep 24, 2022

      Hypoglycemia Trial (Dasiglucagon)

      Not yet recruiting
      • Hypoglycemia
      • (no location specified)
      Feb 2, 2023

      Alcohol Use Disorder Trial (Brief Family-Involved Treatment (B-FIT), Cognitive Behavioral Therapy for Alcohol Use Disorder (CBT

      Not yet recruiting
      • Alcohol Use Disorder
      • Brief Family-Involved Treatment (B-FIT)
      • Cognitive Behavioral Therapy for Alcohol Use Disorder (CBT for AUD)
      • (no location specified)
      Dec 21, 2022

      Radiation Toxicity Trial in Taipei (fucoidan)

      Recruiting
      • Radiation Toxicity
      • fucoidan
      • Taipei, Please Select, Taiwan
        Szu-Yuan Wu
      Nov 13, 2022

      Assessment of Brain Cognitive Impairment in Breast Cancer

      Recruiting
      • Breast Cancer
      • +2 more
      • PET/MRI, psychobehavioral tests and questionnaires, serum biomarkers and stool sample
      • Xi'an, Shaanxi, China
        Tangdu Hospital
      Jul 12, 2022

      Hiv Trial in Cape Town (Dolutegravir)

      Recruiting
      • Hiv
      • Cape Town, Western Cape, South Africa
        Tygerberg Hospital
      Oct 18, 2022

      NSCLC Trial in Australia, China, Korea, Republic of (AZD9291)

      Active, not recruiting
      Has Results
      • Non-Small Cell Lung Cancer
      • Kogarah, Australia
      • +29 more
      Oct 20, 2022

      Metastatic Prostate Cancer, Prostate Adenocarcinoma Trial in Worldwide (Cabozantinib, Atezolizumab, Abiraterone Acetate)

      Recruiting
      • Metastatic Prostate Cancer
      • Prostate Adenocarcinoma
      • Tucson, Arizona
      • +259 more
      Oct 19, 2022

      Difference in the Change in Cardiovascular Risk in Treatment Resistant Schizophrenia Trial (Aripiprazole 10 MG)

      Not yet recruiting
      • Difference in the Change in Cardiovascular Risk in Treatment Resistant Schizophrenia
      • Aripiprazole 10 MG
      • (no location specified)
      Mar 10, 2023